New Zealand makes cannabis legal for terminally ill with further decriminalisation to follow in a year

New Zealand’s Government has passed a law – by 63 votes to 53 – that will “make medical marijuana widely available for thousands of patients over time”. The legislation will allow terminally ill patients to begin smoking illegal pot immediately without facing the possibility of prosecution. However, patients suffering with chronic pain will have to […]

Continue Reading

This Week In Weed – 9 December 2018

WHO delays cannabis scheduling recommendation The World Health Organization (WHO) postponed much-anticipated recommendations about the international scheduling of cannabis which were due to be announced on Friday, saying that more time is needed to review its findings. WHO was due to present its findings to the United Nations’ Commission on Narcotic Drugs (CND) 61st reconvened […]

Continue Reading

Mother says she may have to sell house to pay for epileptic daughter’s cannabis medicine

A mother of a seven-year-old girl with epilepsy says she may have to sell the family’s home to pay for treatment abroad because they have not been able to get a prescription on the NHS. Sam Fairlie, from Leicester, wants her daughter Maya to try Bedrocan – which Carly Barton has been prescribed on an […]

Continue Reading

Luxembourg to become first EU country to legalise recreational cannabis

In a milestone development for Europe, Luxembourg looks likely to become the first country in the EU to legalise cannabis, including recreationally. While cannabis is decriminalised or tolerated in the Netherlands, Portugal, Spain and the Czech Republic – and most EU countries currently allow some form of medical cannabis – Luxembourg is the first to pursue […]

Continue Reading

MS patient whose life was transformed during four-week Sativex trial denied prescription on NHS because it isn’t ‘cost-effective’

A multiple sclerosis (MS) patient who described cannabis extract drug Sativex as a “miracle drug” after a four-week trial has been told that she would have to pay £450 a month to have it prescribed, as is not funded on the NHS locally because of national guidance about its “cost-effectiveness”. Sally Deegan was diagnosed with […]

Continue Reading